1.Sarin SK, Kedarisetty CK, Amarapukar D, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. Hepatology International, 2014. 8(4): 453–71.
2.Volarevic V, Markovic BS, Gazdic M, et al. Ethical and Safety Issues of Stem Cell-Based Therapy. International Journal of Medical Sciences, 2018. 15(1): 36–45.
3.Besch C, Michard B, Addeo P, et al., Impact of early remote organ dysfunction on long-term survival after liver transplantation. Clin Res Hepatol Gastroenterol, 2019.
4.Antunes A G, Teixeira C, Vaz AM, et al. Comparison of the prognostic value of Chronic Liver Failure Consortium scores and traditional models for predicting mortality in patients with cirrhosis. Gastroenterología y Hepatología, 2017, 40(4):276–85.
5.Premkumar M, saena P, Rangeowda D, et al, Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute-on-chronic liver failure: An observational cohort study. Liver Int, 2019, 39(4): 694–704.
6.Trebicka J, Amoros A, Pitarch C, et al, Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis. Front Immunol, 2019, 10: 476.
7.Clària J, Stauber RE, Coenraad MJ, et al, systemic inflammation in decompensated cirrhosis. Characterization and role in acute-on-chronic liver failure. Hepatology, 2016, 64(4):1249–64.
8.Cetinkaya E, Senol K, Saylam B, et al, Red cell distribution width to platelet ratio: new and promising prognostic marker in acute pancreatitis. World J Gastroenterol, 2014, 20(39): 14450–4.
9.Bendall LJ, Bradstock KF, G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent. Cytokine Growth Factor Rev, 2014, 25(4): 355–67.
10.Kaser A, Brandacher G, Steurer W, et al., Interleukin–6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood, 2001, 98(9): 2720–5.
11.Ceylan B, Fincanci M, Yardimci C, et al, Can mean platelet volume determine the severity of liver fibrosis or inflammation in patients with chronic hepatitis B? Eur J Gastroenterol Hepatol, 2013, 25(5): 606–12.
12.Liu H, Zhang H, Wan G, Sang Y, et al, Neutrophil-lymphocyte ratio: a novel predictor for short-term prognosis in acute-on-chronic hepatitis B liver failure. J Viral Hepat, 2014, 21(7): 499–507.
13.Karagöz E, Tanoğlu A, Ülçay A, et al. Mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in patients with chronic hepatitis C. European journal of gastroenterology & hepatology, 2016, 28(7):744–8.
14.Wu J, Zhang X, Liu H, et al, RDW, NLR and RLR in predicting liver failure and prognosis in patients with hepatitis E virus infection. Clin Biochem, 2019. 63: 24–31.
15.Cai J, Wang K, Han T, Jiang H, Evaluation of prognostic values of inflammation-based makers in patients with HBV-related acute-on-chronic liver failure. Medicine (Baltimore), 2018, 97(46): e13324.
16.Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association Guideline for diagnosis and treatment of liver failure.Zhonghua Gan Zang Bing Za Zhi 2019;27:18–26.
17.Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology, 2002, 35(3):716–21.
18.Søren Møller, EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. Journal of Hepatology, 2010, 53(3):397–417.
19.Kamath PS and Kim WR, The model for end-stage liver disease (MELD). Hepatology, 2010. 45(3): 797–805.
20.Biggins SW, Kim WR, Terrault NA, et al. Evidence-Based Incorporation of Serum Sodium Concentration Into MELD. Digest of the World Core Medical Journals(Gastroenterology), 2006, 130(6):1652–60.
21.Zhou C, Hou C, Cheng D, et al. Predictive accuracy comparison of MELD and Child-Turcotte-Pugh scores for survival in patients underwent TIPS placement: a systematic meta-analytic review. International Journal of Clinical & Experimental Medicine, 2015.
22.Bernardi M, Moreau R, Angeli P, et al. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. J Hepatol, 2015. 63(5): 1272–84.
23.Moreau, R, The Pathogenesis of ACLF: The Inflammatory Response and Immune Function. Semin Liver Dis, 2016. 36(2): 133–40.
24.Rocha NP and Fortes RC, Total lymphocyte count and serum albumin as predictors of nutritional risk in surgical patients. Arq Bras Cir Dig, 2015. 28(3): 193–6.
25.Yoshitomi R, Nakayama M, Sakoh T, et al, High neutrophil/lymphocyte ratio is associated with poor renal outcomes in Japanese patients with chronic kidney disease. Ren Fail, 2019, 41(1): 238–43.
26.Sargin G, Senturk T, Yavasoqlu I, et al, Relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio and disease activity in rheumatoid arthritis treated with rituximab. International Journal of Rheumatic Diseases, 2018, 21(12): 2122–7.
27.Peng Y, Li Y, Wei Q, et al, The role of neutrophil to lymphocyte ratio for the assessment of liver fibrosis and cirrhosis: a systematic review. Expert Rev Gastroenterol Hepatol, 2018, 12(5):503–13.
28.Wong L, Bozhilov K, Hernandez B, et al. Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio. Clin Mol Hepatol, 2019.
29.Albillos A, Lario M and Alvarez-Mon M, Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol, 2014, 61(6):1385–96.
30.Kwon JH, Jang JW, Kim YW, et al, The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis. BMC Gastroenterol, 2015, 15: 146.
31.Lippi GM and Plebani M, Red blood cell distribution width (RDW) and human pathology. One size fits all. Clin Chem Lab Med, 2014, 52(9):1247–9.
32.Semba RD, Patel KV, Ferrucci L, et al, Serum antioxidants and inflammation predict red cell distribution width in older women: the Women’s Health and Aging Study I. Clin Nutr, 2010, 29(5):600–4.
33.Tefferi A, Anemia in Adults: A Contemporary Approach to Diagnosis. Mayo Clinic Proceedings, 2003. 78(10): 1274–80.
34.Friedman JS, Lopez MF, Fleming MD, et al. SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood. 2004;104(8):2565–73.